An experimental minimally invasive perfusion technique for the treatment of liver metastases

European Journal of Surgical Oncology

Volumn 29, Issue 9, 2003, Pages 757-763

  Rothbarth, J ^a,b   Pijl, M E J ^a   Tollenaar, A E M ^a   Tijl, F ^a   Ivancev, G ^c   Mulder, G J ^b   Kuppen, P J K ^a   van de Velde, C J H ^a   Schultze Kool, L J ^a,d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c MALMÖ UNIVERSITY   (Sweden)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Isolated hepatic perfusion; Minimally invasive; Pigs

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BALLOON CATHETER; CONTROLLED STUDY; ISOLATION PROCEDURE; LIVER METASTASIS; LIVER PERFUSION; MINIMALLY INVASIVE SURGERY; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; STENT; SWINE; SYSTEMIC CIRCULATION; VEIN BLOOD FLOW; VENOUS REFLUX;

EID: 0344033783     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2003.08.004     Document Type: Article

References (21)

1. Ausman RK. Development of a technic for isolated perfusion of the liver. NY State J Med 1961; 61: 3393-7.
2. Vahrmeijer AL, van Dierendonck JH, Keizer HJ, Beijnen JH, Tollenaar RA, Pijl ME et al. Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver. Br J Cancer 2000; 82: 1539-46.
3. Alexander HR, Libutti SK, Bartlett DL, Puhlmann M, Fraker DL, Bachenheimer LC. A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver. Clin Cancer Res 2000; 6: 3062-70.
4. Alexander HR Jr, Bartlett DL, Libutti SK, Fraker DL, Moser T, Rosenberg SA. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver. J Clin Oncol 1998; 16: 1479-89.
5. Aigner KR, Walther H, Link KH. Isolated liver perfusion with MMC/5-FU: surgical technique, pharmacokinetics, clinical results. Contrib Oncol 1988; 29: 229-46.
6. Hafstrom LR, Holmberg SB, Naredi PL, Lindner PG, Bengtsson A, Tidebrant G et al. Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy. Surg Oncol 1994; 3: 103-8.
7. Marinelli A, de Brauw LM, Beerman H, Keizer HJ, van Bockel JH, Tjaden UR et al. Isolated liver perfusion with mitomycin C in the treatment of colorectal cancer metastases confined to the liver. Jpn J Clin Oncol 1996; 26: 341-50.
8. Oldhafer KJ, Lang H, Frerker M, Moreno L, Chavan A, Flemming P et al. First experience and technical aspects of isolated liver perfusion for extensive liver metastasis. Surgery 1998; 123: 622-31.
9. Bartlett DL, Libutti SK, Figg WD, Fraker DL, Alexander HR. Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer. Surgery 2001; 129: 176-87.
10. de Vries MR, Rinkes IH, van de Velde CJ, Wiggers T, Tollenaar RA, Kuppen PJ et al. Isolated hepatic perfusion with tumor necrosis factor alpha and melphalan: experimental studies in pigs and phase I data from humans. Recent Results Cancer Res 1998; 147: 107-19.
11. Rothbarth J, Pijl MEJ, Vahrmeijer AL, Hartgrink HH, Tijl FGJ, Tollenaar RA et al. Isolated hepatic perfusion with high dose melphalan for the treatment of metastatic colorectal cancer confined to the liver. Br J Surg 2003; in press.
12. Gallego C, Velasco M, Marcuello P, Tejedor D, De Campo L, Friera A. Congenital and acquired anomalies of the portal venous system. Rodiographics 2002; 22: 141-59.
13. Rothbarth J, Sparidans RW, Beijnen JH, Schultze Kool LJ, Putter H, van de Velde CJ et al. Reduced liver uptake of arterially infused melphalan during retrograde rat liver perfusion with unaffected liver tumor uptake. J Pharmacol Exp Ther 2002; 303: 736-40.
14. Runia RD, de Brauw LM, Kothuis BJ, Pauwels EK, van de Velde CJ. Continuous measurement of leakage during isolated liver perfusion with a radiotracer. Int J Radiat Appl Instrum B 1987; 14: 113-8.
15. Vahrmeijer AL, van Dierendonck JH, van de Velde CJ. Treatment of colorectal cancer metastases confined to the liver. Eur J Cancer 1995; 31A: 1238-42.
16. van ljken MG, de Bruijn EA, de Boeck G, ten Hagen TL, van der Sijp JR, Eggermont AM. Isolated hypoxic hepatic perfusion with tumor necrosis factor-alpha, melphalan, and mitomycin C using balloon catheter techniques: a pharmacokinetic study in pigs. Ann Surg 1998; 228: 763-70.
17. Compagnon P, Clement B, Campion JP, Boudjema K. Effects of hypothermic machine perfusion on rat liver function depending on the route of perfusion. Transplantation 2001; 72: 606-14.
18. Sigurdson ER, Ridge JA, Kemeny N, Daly JM. Tumor and liver drug uptake following hepatic artery and portal vein infusion. J Clin Oncol 1987; 5: 1836-40.
19. Wang LQ, Persson BG, Stenram U, Bengmark S. Influence of portal branch ligation on the outcome of repeat dearterializations of an experimental liver tumor in the rat. J Surg Oncol 1994; 55: 229-34.
20. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 2000; 231: 480-6.
21. In: Casteneda-Zuniga WR, Tadavarthy SM (eds) Interventional Radiology. Baltimore: Williams and Wilkins, 1991.